Delivery Order SPE2DB22D2006-SPE2DB24FV9VV
- Not listed
- This federal contract award is for the supply of RABAVERT rabies vaccine with diluents, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $14,477.25 firm fixed-price delivery order contract has an ultimate completion date of April 19, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $3,860.60 firm fixed price delivery order has a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of medical commodities,...
- This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS to the U.S. Defense Logistics Agency (DLA). The $3,860.60 firm fixed price contract was awarded to the Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that holds several large indefinite delivery contracts (IDCs) with the DLA and other federal agencies. The contract has no set-aside designation and is a delivery order awarded under Amerisourcebergen's...
- This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS, valued at $50,393.66. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of May 9, 2023 and is a Firm Fixed Price delivery order. This contract award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of RABAVERT rabies vaccine with diluents. The $1,737.27 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. No set-aside designations were used. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is for the provision of RABAVERT rabies vaccine with diluents to the U.S. government. The $53,477.69 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). This award is part of a larger Indefinite Delivery Contract...
- This federal contract award is for the delivery of RABAVERT rabies vaccine and diluents, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,960.11 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS, valued at $4,191.60, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of the RABAVERT rabies vaccine with diluents to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,421.72, was awarded to the Corporate Office Division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a firm-fixed price delivery order with a completion date of July 15, 2024. This award is a part of Amerisourcebergen's larger Indefinite...
- This federal contract award is for the supply of RABAVERT Rabies Vaccine with diluents, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,441.89 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through July 2, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV9VVDelivery Order
This federal contract award is for the supply of RABAVERT RABIES VACCINE with diluents to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $3,088.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has an ultimate completion date of April 26, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025, which serves as the primary vehicle for the company to provide a broad range of pharmaceutical products and medical supplies to the Department of Defense globally. Amerisourcebergen also has a smaller IDC valued up to $750,000 with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 4/25/24 |